-
2, 2026, 11:59pm EST Course number and title: MMG3001Y: Advanced Human Genetics Course description: This two-term graduate course is offered within the MHSc Medical Genomics program, and is restricted
-
: Online synchronous Estimated enrolment: 10 Estimated TA support: None Qualifications: A PhD or Masters level education with experience in health informatics, preferably in the areas of data governance and
-
Biotechnology with focus on Translational Quantitative Biomedical Imaging: an early-career researcher who will build an independent program developing and applying quantitative biomedical imaging methods and/or
-
Canada Impact+ Emerging Leader is conditional upon their approval. Consult the Canada Impact+ Emerging Leader recruitment website https://www.canada.ca/en/impact-plus-chairs/program-details/competition
-
for selected courses related to the M.Eng. biomanufacturing program and M.Sc. concentration in Synthetic Biology Qualifications and Education Requirements: Candidates must have a PhD in Chemical
-
computational modeling. These systems contribute to new methodologies for studying the fundamental biological mechanisms that govern interactions at all levels of complexity, ranging from molecules to communities
-
. Work will be focused on investigating and analyzing the biochemical mechanisms that regulate myelination and remyelination in the central nervous system. The focus of the candidate’s core project will
-
Director of the UBC MS & Neuromyelitis Optica Program. His laboratory combines human discovery science with advanced experimental technologies to understand disease mechanisms and develop precision
-
. The Quandt Laboratory at the University of British Columbia is seeking a highly motivated Postdoctoral Fellow to lead an independent research project investigating mechanisms of inflammation, tissue
-
University of British Columbia Department of Surgery | Northern British Columbia Fort Nelson, British Columbia | Canada | about 2 months ago
biology and gene engineering approaches Developing in vivo strategies to generate antigen-specific Tregs using targeted delivery technologies, including lipid nanoparticles Discovering novel mechanisms by